title: Obese carboxypeptidase E knockout mice exhibit multiple defects in peptide hormone processing contributing to low bone mineral density.
abstract: Carboxypeptidase E (CPE) is a prohormone/proneuropeptide processing enzyme, and mice bearing CPE mutations exhibit an obese and diabetic phenotype. Studies on CPE knockout (KO) mice revealed poor prohormone processing, resulting in deficiencies in peptide hormones/neuropeptides such as insulin, gonadotropin-releasing hormone, and cocaine- and amphetamine-regulated transcript (CART). Here, we show that CPE KO mice, an obese animal model, have low bone mineral density (BMD) accompanied by elevated plasma CTX-1 (carboxy-terminal collagen crosslinks), and osteocalcin, indicators of increased bone turnover. Receptor activator for NF-kappaB ligand (RANKL) expression was elevated approximately 2-fold relative to osteoprotegerin in the femur of KO animals, suggesting increased osteoclastic activity in the KO mice. In the hypothalamus, mature CART, a peptide involved in eating behavior and implicated in bone metabolism, was undetectable. The melanocortin and neuropeptide Y (NPY) systems in the hypothalamus have also been implicated in bone remodeling, since MC4R KO and NPY KO mice have increased BMD. However, reduction of alpha-MSH, the primary ligand of MC4R by up to 94% and the lack of detectable NPY in the hypothalamus of CPE KO do not recapitulate the single-gene KO phenotypes. This study highlights the complex physiological interplay between peptides involved in energy metabolism and bone formation and furthermore suggests the possibility that patients, bearing CPE and CART mutations leading to inactive forms of these molecules, may be at a higher risk of developing osteoporosis.
authors.affiliation: Section on Cellular Neurobiology, Program on Developmental Neuroscience,Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, 49 Convent Dr., Bethesda, MD 20892, USA.
authors.forename: Niamh X
authors.initials: NX
authors.lastname: Cawley
authors.forename: Tulin
authors.initials: T
authors.lastname: Yanik
authors.forename: Alicja
authors.initials: A
authors.lastname: Woronowicz
authors.forename: Weizhong
authors.initials: W
authors.lastname: Chang
authors.forename: Joan C
authors.initials: JC
authors.lastname: Marini
authors.forename: Y Peng
authors.initials: YP
authors.lastname: Loh
mesh_terms: D015502:Absorptiometry, Photon; D000818:Animals; D015415:Biomarkers; D015519:Bone Density / Q000502:physiology*; D016723:Bone Remodeling / Q000502:physiology; D001862:Bone Resorption / Q000235:genetics / Q000378:metabolism; D002118:Calcium / Q000097:blood; D043423:Carboxypeptidase H / Q000235:genetics* / Q000502:physiology*; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D007031:Hypothalamus / Q000378:metabolism; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D009419:Nerve Tissue Proteins / Q000235:genetics / Q000378:metabolism; D009478:Neuropeptide Y / Q000378:metabolism; D009765:Obesity / Q000201:enzymology*; D010010:Osteoclasts / Q000378:metabolism; D053244:Osteoprotegerin / Q000096:biosynthesis; D036361:Peptide Hormones / Q000378:metabolism*; D052716:Pituitary Gland, Intermediate / Q000378:metabolism; D040081:Protein Array Analysis; D053245:RANK Ligand / Q000096:biosynthesis / Q000235:genetics; D000521:alpha-MSH / Q000378:metabolism; D000098882:Cocaine- and Amphetamine-Regulated Transcript Protein
chemical_list: D015415:Biomarkers; D009419:Nerve Tissue Proteins; D009478:Neuropeptide Y; D053244:Osteoprotegerin; D036361:Peptide Hormones; D053245:RANK Ligand; C505689:Tnfsf11 protein, mouse; D000098882:Cocaine- and Amphetamine-Regulated Transcript Protein; D000521:alpha-MSH; D043423:Carboxypeptidase H; D002118:Calcium
references.citation: Endocrinology. 2006 Jan;147(1):39-43
references.pmid: 16210370
references.citation: Hum Mutat. 2001 Aug;18(2):120-31
references.pmid: 11462236
references.citation: Neuron. 2005 Jan 20;45(2):245-55
references.pmid: 15664176
references.citation: Nature. 2005 Mar 24;434(7032):514-20
references.pmid: 15724149
references.citation: Proc Natl Acad Sci U S A. 2008 Apr 1;105(13):5266-70
references.pmid: 18362359
references.citation: Proc Natl Acad Sci U S A. 1984 May;81(9):2776-80
references.pmid: 6326144
references.citation: Cell. 1997 Jan 10;88(1):73-83
references.pmid: 9019408
references.citation: Endocrinology. 2006 Jul;147(7):3196-202
references.pmid: 16614075
references.citation: Am J Physiol Cell Physiol. 2002 Jul;283(1):C244-50
references.pmid: 12055093
references.citation: Mol Cell Neurosci. 2008 Sep;39(1):63-73
references.pmid: 18573344
references.citation: Diabetologia. 1998 Jun;41(6):701-5
references.pmid: 9662053
references.citation: Cell. 1997 Apr 18;89(2):309-19
references.pmid: 9108485
references.citation: J Musculoskelet Neuronal Interact. 2008 Apr-Jun;8(2):146-53
references.pmid: 18622083
references.citation: J Lipid Res. 2005 Jul;46(7):1369-79
references.pmid: 15834118
references.citation: Peptides. 2006 Aug;27(8):2024-30
references.pmid: 16759747
references.citation: J Neurosci Res. 2010 Jan;88(1):64-72
references.pmid: 19598241
references.citation: J Neuroendocrinol. 1997 Nov;9(11):823-33
references.pmid: 9419833
references.citation: Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):3258-63
references.pmid: 14978271
references.citation: Proc Natl Acad Sci U S A. 1982 Jun;79(12):3886-90
references.pmid: 6808517
references.citation: J Neurosci. 2009 Jun 24;29(25):8248-58
references.pmid: 19553464
references.citation: Bone. 2004 Jul;35(1):96-107
references.pmid: 15207745
references.citation: FEBS Lett. 1999 Mar 26;447(2-3):139-43
references.pmid: 10214934
references.citation: Cell. 1998 Apr 17;93(2):165-76
references.pmid: 9568710
references.citation: Diabetes. 2001 Sep;50(9):2157-60
references.pmid: 11522684
references.citation: Cell. 1997 Jan 10;88(1):131-41
references.pmid: 9019399
references.citation: Hippocampus. 2008;18(10):1051-63
references.pmid: 18570185
references.citation: Trends Endocrinol Metab. 2008 Jul;19(5):161-6
references.pmid: 18407515
references.citation: Trends Endocrinol Metab. 1999 Aug;10(6):211-216
references.pmid: 10407394
references.citation: J Clin Invest. 2002 Apr;109(7):915-21
references.pmid: 11927618
references.citation: Mol Biol Rep. 2009 Feb;36(2):245-54
references.pmid: 18080843
references.citation: Bone. 2005 May;36(5):820-31
references.pmid: 15804492
references.citation: Cell. 2002 Nov 1;111(3):305-17
references.pmid: 12419242
references.citation: Endocrinology. 2004 Dec;145(12):5807-19
references.pmid: 15358678
references.citation: Mol Brain. 2009 May 06;2:10
references.pmid: 19419578
references.citation: Proc Natl Acad Sci U S A. 2008 Dec 23;105(51):20529-33
references.pmid: 19074282
references.citation: Peptides. 1988 Sep-Oct;9(5):1027-36
references.pmid: 3244556
references.citation: Endocrinology. 2008 Aug;149(8):3933-41
references.pmid: 18450969
references.citation: Mol Endocrinol. 2008 Apr;22(4):989-1005
references.pmid: 18202146
references.citation: J Neurochem. 2005 Dec;95(5):1351-62
references.pmid: 16219026
references.citation: PLoS One. 2009 Dec 22;4(12):e8415
references.pmid: 20027231